Search Our Site
Search Results
345 Results Found
SF sees slight uptick in HIV cases as advocates fear funding cuts
New HIV diagnoses saw a slight uptick in San Francisco in 2024 and rose by about 1,000 cases nationwide in 2023, according to the latest surveillance reports from the San Francisco Department of Public Health and the CDC.
NIH axes HIV research funding
The Trump administration continues to make cuts that threaten people living with, or at risk for, HIV and sexually transmitted infections, including cancellation of National Institutes of Health research grants.
Federal health department cuts state COVID funding
The Trump administration has canceled COVID funding for state and local health departments, which is also being used to support public health infrastructure.
Federal health department slashes CDC, NIH staff
In what is being described as a “bloodbath,” the Department of Health and Human Services has dramatically reduced personnel at the Centers for Disease Control and Prevention and other federal health agencies.
HIV confab hears news about cures, once-yearly PrEP
While the Trump administration’s threats to HIV research and services were an inescapable theme at the opening session of the recent Conference on Retroviruses and Opportunistic Infections, participants also heard plenty of science news.
Researchers report sustained impact of doxyPEP for STI prevention
Research continues to confirm that taking doxycycline after sex – an approach known as doxyPEP – reduces the risk of sexually transmitted infections.
CDC's HIV prevention division reportedly under threat
The Trump administration may be planning to eliminate the Centers for Disease Control and Prevention's Division of HIV Prevention, possibly as soon as this week, news sources reported late Tuesday, March 18.
FDA may be cracking down on poppers
The federal Food and Drug Administration raided a major seller of poppers last week, and other brands have shut down their websites and social media.
HIV confab opens in San Francisco with call to action
A major annual HIV conference opened in San Francisco Sunday, March 9, under a cloud of uncertainty in the face of the Trump administration's attacks on government health and science efforts.
Twice-yearly PrEP could be available this summer
Twice-yearly lenacapavir PrEP could be available as early as this summer pending federal Food and Drug Administration approval, with a decision expected in mid-June, Gilead Sciences Inc. announced Tuesday.
CDC, other agencies scrub HIV, transgender web content
The Centers for Disease Control and Prevention and other federal agencies have altered or removed hundreds of pages of HIV-related information on their websites, part of a government-wide purge of content that conflicts with President Trump's policies.
Trump halts PEPFAR funding, withdraws from WHO
In the first week after his inauguration, President Donald Trump has stopped funding for PEPFAR, the President's Emergency Plan for AIDS Relief, jeopardizing the lives of people who receive HIV prevention and treatment through the global aid program.
More evidence that doxyPEP reduces STIs
The early rollout of doxyPEP – a dose of the antibiotic doxycycline after sex – has contributed to a decline in sexually transmitted infections in Northern California, according to a pair of studies published this week.
Gilead's twice-yearly PrEP chosen as breakthrough of the year
Science magazine has chosen twice-yearly lenacapavir PrEP as its 2024 Breakthrough of the Year, recognizing it as a game-changer in the fight to end the global HIV epidemic.
First clade I mpox variant case reported in San Mateo County
The first U.S. case of a potentially more severe variant of mpox, known as clade I, has been reported in San Mateo County, the California Department of Public Health announced Saturday, November 16.
SF Night Ministry celebrates 60 years
The San Francisco Night Ministry, best known for its outreach to people experiencing homelessness in the Tenderloin, celebrated 60 years of service on November 1.
Study: Twice-yearly PrEP works for gay men, trans women
Lenacapavir, a twice-yearly injectable antiretroviral, reduced the risk of HIV infection by 96% in a large study of gay and bisexual men and gender diverse people, according to a Gilead Sciences announcement.
Pioneering bi activist Marguerite 'Maggi' Rubenstein dies
Marguerite "Maggi" Rubenstein, Ph.D., a pioneering bisexual activist dubbed the Godmother of Sex Ed, died August 19 at her home in Red Bluff, California.
WHO declares mpox an international emergency
The World Health Organization on August 14 declared that the upsurge of mpox in the Democratic Republic of the Congo and nearby countries is a public health emergency of international concern.
AIDS confab hears bad news about funding, good news about PrEP
The 25th International AIDS Conference kicked off Monday, July 22, in Munich, Germany with calls to redouble efforts to end the global epidemic as funding cuts and threats to the rights of LGBTQ people and other vulnerable populations jeopardize progress.